Sun Pharma Advanced Research Company Limited — Others, 17-01-2025: Change in Management

Dr. Venkata Palle, Executive Vice President - Global Head Drug Discovery & Preclinical Development, has been transferred to SPARCLIFE Inc. as Executive Vice President – Small Molecules. This move is primarily due to his relocation to the U.S. for personal reasons. Dr. Palle will lead scientific strategy and small molecule discovery programs at the subsidiary, but will no longer participate in SPARC's senior management team. This strategic shift may enhance expertise within SPARCLIFE, potentially benefiting operational outcomes and aligning growth strategies in drug development, fostering a positive outlook among investors.